Search results
Japan's Astellas to buy Iveric Bio for $5.9 billion to expand eyesight treatments
Reuters via Yahoo News· 1 year agoTOKYO (Reuters) -Japan's Astellas Pharma said on Monday it agreed to buy U.S. drugmaker Iveric Bio...
TOKYO (Reuters) -Japan's Astellas Pharma said on Monday it agreed to buy U.S. drugmaker Iveric Bio...